U.S. Specialized REITs Stock News

We wouldn't blame PTC Therapeutics, Inc. ( NASDAQ:PTCT ) shareholders if they were a little worried about the fact that...

Korro Bio, Inc. ( NASDAQ:KRRO ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...

Readers hoping to buy The Bank of N.T. Butterfield & Son Limited ( NYSE:NTB ) for its dividend will need to make their...

The quarterly results for Primerica, Inc. ( NYSE:PRI ) were released last week, making it a good time to revisit its...

As you might know, D-Wave Quantum Inc. ( NASDAQ:QBTS ) last week released its latest quarterly, and things did not turn...

What Cirrus Logic’s latest quarter tells you Cirrus Logic (CRUS) just reported record Q1 revenue of about $460 million with record GAAP EPS of $1.47, backed by strong smartphone audio demand and expanding high performance mixed signal products. The company paired those results with Q2 revenue guidance of $510 million to $570 million, a new capacity reservation agreement with GlobalFoundries for 2027 and 2028, and ongoing share buybacks funded from a cash balance of about $1.2 billion and no...

Xencor, Inc. ( NASDAQ:XNCR ) just released its quarterly report and things are looking bullish. Revenue crushed...

Dividend declarations frame the latest Regency Centers update Regency Centers (REG) has just declared quarterly cash dividends on its common and preferred stock, with upcoming payment and record dates that matter for income focused shareholders tracking the stock’s yield profile. See our latest analysis for Regency Centers. Regency Centers’ recent dividend declarations come shortly after its late July earnings release and slightly higher full year guidance. The stock at $77.12 shows a 13.48%...

Just because a business does not make any money, does not mean that the stock will go down. By way of example, Climb...

It's been a mediocre week for Insulet Corporation ( NASDAQ:PODD ) shareholders, with the stock dropping 15% to US$141...

Bunge Global (BG) is back in focus after reporting Q2 2026 results and updating investors on Viterra integration progress, full year earnings guidance and ongoing share repurchases. See our latest analysis for Bunge Global. At a share price of US$108.38, Bunge Global has seen its 90 day share price return fall 13.25%. However, the year to date share price return of 16.99% and 1 year total shareholder return of 34.35% point to momentum that has built over a longer period as investors respond...

A rare mix of stronger Canadian jobs data, softer U.S. hiring and rising gold and oil prices is reshaping where money is flowing right now. When employment and geopolitics pull markets in different directions, some stocks tied to these themes can quietly move into the spotlight. This article walks through 3 stocks from our Gold and Oil Companies With Tailwinds From Jobs and Geopolitics screener that appear closely linked to these latest shifts. Newmont (NEM) Newmont is a global gold producer...

Energy prices remain closely tied to Hormuz Strait access talks, which keeps attention on supply security and global defense capabilities. That spotlight on geopolitical risk makes Aerospace and Defense stocks more interesting for investors who want direct exposure to these long running themes. This article walks through three stocks from our Aerospace And Defense screener that stand out on fundamentals, business quality, and potential resilience across different market conditions. The three...

A week ago, Warner Music Group Corp. ( NASDAQ:WMG ) came out with a strong set of third-quarter numbers that could...

FirstEnergy earnings snapshot and recent context FirstEnergy (FE) recently reported second quarter 2026 results, with revenue of US$3,678 million and net income of US$288 million. Earnings per share from continuing operations were US$0.50 on both a basic and diluted basis. For the first half of 2026, revenue was US$7,880 million and net income was US$693 million, with basic and diluted earnings per share from continuing operations of US$1.20. These figures provide investors with updated...

HCA Healthcare (HCA) is back in focus after it sharply reduced its full year 2026 profit outlook. The company cited an unfavorable payer mix that cut second quarter revenue by about US$400 million and prompted a securities investigation. See our latest analysis for HCA Healthcare. The share price reaction to HCA Healthcare’s reduced 2026 profit outlook was sharp, with a 6.95% fall on 14 July after the guidance cut and securities investigation disclosure. The stock now trades at US$413.36,...

Why Nextpower stock is back in focus after earnings and guidance update Nextpower (NXT) is back on many investors’ radars after its first quarter fiscal 2027 results, a guidance increase for the full year, and fresh commentary on acquisitions and capital returns. The company reported first quarter sales of US$935.17 million compared with US$864.25 million a year earlier, and net income of US$165.36 million versus US$157.18 million. Basic earnings per share from continuing operations were...

Cohu (COHU) drew investor attention after reporting second quarter 2026 results on July 30, with sales of US$149 million and a sharply reduced net loss, alongside new third quarter sales guidance. See our latest analysis for Cohu. Cohu's recent earnings update and third quarter sales guidance arrived alongside strong momentum, with a year to date share price return of 114.87% and a 1 year total shareholder return of 172.72%. This suggests investors have been reassessing both growth potential...

In the lead-up to its August 13 earnings release, StoneCo drew attention as Wall Street projected higher revenue and earnings for the June 2026 quarter, while analyst sentiment turned more cautious about an earnings beat. This mix of optimism about StoneCo’s core Brazilian payments and fintech franchise and skepticism around short-term earnings outperformance has sharpened investor focus on the quality and resilience of its growth drivers. Against this backdrop of heightened expectations for...

Sylvamo Corporation reported its second-quarter 2026 results, with sales of US$806 million and a net loss of US$11 million, reversing net income a year earlier. The shift from earnings per share of US$0.37 to a loss of US$0.28 from continuing operations highlights mounting pressure on profitability despite slightly higher sales. We’ll now examine how this swing to a quarterly net loss may affect Sylvamo’s investment narrative and longer-term earnings outlook. Invest in the nuclear...

ACADIA Pharmaceuticals Inc. ( NASDAQ:ACAD ) just released its quarterly report and things are looking bullish. It was...

In late July 2026, Masco Corporation reported second-quarter 2026 results showing sales of US$1,992 million versus US$2,051 million a year earlier, while net income rose to US$318 million and diluted EPS from continuing operations increased to US$1.60. Alongside higher year-on-year profitability, Masco raised its full-year 2026 earnings guidance and completed a US$529.04 million share repurchase program, signaling management’s confidence and continued focus on capital returns. We’ll now...

Harrow (HROW), an eyecare pharmaceutical company, continues to attract attention as investors weigh its recent share performance, business mix across branded and compounding segments, and the implications for the stock’s current US$40.44 trading level. See our latest analysis for Harrow. The recent 1-day share price return of 1.30% and 7-day share price return of 4.31% come after a 30-day share price decline of 10.27%. At the current US$40.44 level, a 1-year total shareholder return of 17.46%...

Last week, Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) stock jumped 14%, but insiders who sold US$527k worth of stock in...